m-Power心脏项目:护士协调员主导的移动健康干预改善印度高血压管理——整群随机试验研究方案
该整群随机试验在印度维沙卡帕特南12个社区卫生中心入组1876例≥30岁高血压患者,比较护士协调员使用电子决策支持系统加短信提醒与纸质指南标准治疗的效果。主要结局为12个月收缩压平均变化差异,假设干预组可降低6.5 mmHg。
要点
- 护士协调员借助电子决策支持系统管理高血压,并定期发送短信提醒患者。
- 主要结局为12个月收缩压较基线的平均变化,干预组目标降低6.5 mmHg。
- 次要结局包括舒张压、血压控制率、代谢指标、就诊依从性及成本效果。
核心结论
- 该研究旨在评估护士协调员主导的电子决策支持系统干预能否改善印度资源有限公立医疗体系下的高血压管理。
- 研究预期为印度心血管疾病管理提供可推广的范例。
研究设计与样本
- 整群随机试验,以社区卫生中心为随机化单位,在印度维沙卡帕特南12个社区卫生中心开展。
- 入组1876例≥30岁、收缩压≥160 mmHg或舒张压≥90 mmHg的高血压患者。
- 干预组由受训护士协调员使用基于证据的高血压治疗算法电子决策支持系统,并定期向患者发送短信,持续12个月;对照组接受纸质高血压治疗指南的标准治疗。
主要发现
- 原文为研究方案,未报告试验结果。
关键数值与推荐
- 主要结局为12个月时干预组与标准治疗组收缩压从基线至12个月平均变化值的差异。
- 次要结局包括舒张压平均变化差异、血压控制(<140/90 mmHg)比例差异、空腹血糖/HbA1C/eGFR/白蛋白肌酐比平均变化差异、定期就诊比例差异(实际就诊次数/电子决策支持系统建议就诊次数>80%)、抗高血压药物依从比例差异及成本效果。
- 所有结局在12个月时评估。
临床怎么用
- 原文为研究方案,未提供临床实践推荐。
局限性
- 试验注册为回顾性注册:2017年5月23日注册,首例患者于2017年4月6日入组,因作者未收到印度临床试验注册机构的原始注册回复。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The proportion of patients with controlled hypertension (< 140/90 mmHg) is very low in India. Thus, there is a need to improve blood pressure management among patients with uncontrolled hypertension through innovative strategies directed at health system strengthening. METHODS: We designed an intervention consisting of two important components - an electronic decision support system (EDSS) used by a trained nurse care coordinator (NCC). Based on preliminary data, we hypothesized that this intervention will be able to reduce mean systolic blood pressure by 6.5 mmHg among those with uncontrolled blood pressure in the intervention arm compared to the standard treatment arm (paper-based hypertension treatment guidelines). The study will adopt a cluster randomized trial design with the community health center (CHC) as the unit of randomization. The trial will be conducted in Visakhapatnam district (southern India). A total of 1876 participants aged ≥30 years with high blood pressure - systolic blood pressure (SBP) ≥ 160 mmHg or diastolic blood pressure (DBP) ≥ 90 mmHg will be enrolled from 12 CHCs. The intervention consists of trained NCCs equipped with an evidence-based hypertension treatment algorithm in the form of the EDSS with regular SMSs to patients with hypertension to promote hypertension treatment and blood pressure control for 12 months. The primary outcome will be difference in the mean change of SBP, from baseline to 12 months, between the intervention and the standard treatment arm. The secondary outcomes are the difference in mean change of DBP; difference in the proportion of patients with controlled blood pressure (< 140/90 mmHg); difference in mean change of fasting blood sugar, HbA1C, eGFR, and albumin to creatinine ratio; difference in the proportion of patients visiting the CHC regularly (number of actual visits to the CHC/number of visits suggested by the EDSS > 80%); difference in proportion of patients compliant to anti-hypertensive medication/s; cost-effectiveness of intervention versus enhanced care. All the outcomes will be assessed at 12 months. DISCUSSION: The study is expected to provide evidence on the effectiveness of NCC-led, EDSS-based hypertension management in India and can likely offer an exemplar for improving cardiovascular disease (CVD) management in India within the resource-constrained public healthcare system. TRIAL REGISTRATION: ClinicalTrials.gov, ID: NCT03164317 ). Registered retrospectively on 23 May 2017 (first patient enrolled on 6 April 2017) because the authors did not receive a response to their original registration submission (5 January 2017) to the Clinical Trial Registry - India (CTRI).
引用
- Srinivasapura Venkateshmurthy N, Ajay VS, Mohan S, et al. m-Power Heart Project - a nurse care coordinator led, mHealth enabled intervention to improve the management of hypertension in India: study protocol for a cluster randomized trial. Trials. 2018. PMID: 30086778. doi:10.1186/s13063-018-2813-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。